Faraoni David, Samama Charles Marc, Ranucci Marco, Dietrich Wulf, Levy Jerrold H
Department of Anesthesiology, Queen Fabiola Children's University Hospital, 15 JJ Crocq Avenue, Brussels B-1020, Belgium.
Department of Anesthesia and Intensive Care, Cochin Hotel-Dieu University Hospitals, Place du Parvis Notre-Dame, 1, Paris 75181, France.
Clin Lab Med. 2014 Sep;34(3):637-54. doi: 10.1016/j.cll.2014.06.006. Epub 2014 Jul 23.
New oral anticoagulants (NOACs) are increasingly replacing standard anticoagulants. These new drugs have been recently introduced in clinical practice, and specific knowledge regarding preoperative interruption, anticoagulation assessment, and reversal therapies is needed. In this article, 3 main areas related to perioperative NOACs management are discussed: (1) physicians' knowledge, (2) current practices, and (3) perspectives to improve management of patients treated with NOACs.
新型口服抗凝药（NOACs）正越来越多地取代标准抗凝药。这些新药最近已引入临床实践，因此需要有关术前停药、抗凝评估及逆转治疗的专业知识。本文讨论了与围手术期NOACs管理相关的3个主要方面：（1）医生的知识，（2）当前的做法，以及（3）改善接受NOACs治疗患者管理的前景。
